Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Weekend update, forward look

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Mar 11, 2024 5:20am

163 Views

Post# 35925814

RE:RE:RE:RE:Weekend update, forward look

Oh gosh no, I enjoy interacting with all of you challenged people.

Some of us just don't go around telling people what they can and can't post, free speech must be free for all.

I do, however, reserve the right to make fun of you and the "Bro's" when you pipe up and make yourselves look silly.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant